And another reply:
Though I give the staffers credit, it was not verbatim the same as the last one.
Dear Mr. Petro,
Thank you for contacting me regarding the Food and Drug Administration’s (FDA) regulation of tobacco products. I appreciate your
continued feedback on this important issue.
The Family Smoking Prevention and Tobacco Control Act of 2009 gave the FDA authority to regulate the manufacture, distribution, and marketing of tobacco products. For example, the Tobacco Control Act restricts tobacco marketing and sales to minors, ensures that tobacco companies provide FDA with detailed manufacturing information about their products, allows biannual inspections of tobacco manufacturing and processing facilities, and requires smokeless tobacco products and advertisements to contain product warnings. Additionally, the law requires FDA to create a regulatory framework for newer tobacco products entering the market since February 15, 2007.
On November 15, 2018, then FDA Commissioner Dr. Scott Gottlieb announced a number of steps the FDA is taking to combat youth tobacco use. The agency intends to limit the sale of flavored cigarettes and most flavored e-cigarettes to age-restricted retail settings and websites with heightened age verification practices and combat the marketing of e-cigarettes to children. The FDA is still developing the proposed rule regarding menthol cigarettes. When the Administration releases the Notice of Proposed Rulemaking, there will be a 30 to 60 day window for members of the public to submit comments via regulations.gov for the FDA to consider prior to finalizing the rule.
Again, thank you for contacting me about this issue and please know that I am committed to finding the best regulatory structure available to balance protecting public health with the concerns of all stakeholders.
Sincerely,
MARK R. WARNER
United States Senator